Clinical Trials in Philadelphia

Showing 14841-14860 of 20,904 trials

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

NCT00483678

RATIONALE: A couples therapy program may enhance intimacy and reduce psychological distress in patients with prostate cancer and in their partners. PURPOSE: This randomized clinical trial is studying how well couples therapy enhances intimacy and reduces psychological distress in patients with advanced or recurrent prostate cancer and in their partners.

Prostate CancerPsychosocial Effects of Cancer and Its TreatmentSexual Dysfunction+1 more

Memorial Sloan Kettering Cancer Center64 participantsStarted Apr 2007

New York, New York, United States • Philadelphia, Pennsylvania, United States

COMPLETEDPhase 1/2< 1 mile

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

NCT00305864

This phase I/II trial is studying the side effects and best dose of motexafin gadolinium when given together with temozolomide and radiation therapy and to see how well they work in treating patients with newly diagnosed supratentorial glioblastoma multiforme or gliosarcoma. Drugs used in chemotherapy, such as temozolomide, work in different ways to stop the growth of tumor cells, either by killing the cells or by stopping them from dividing. Motexafin gadolinium may help temozolomide work better by making tumor cells more sensitive to the drug. Radiation therapy uses high-energy x-rays to kill tumor cells. Motexafin gadolinium may also make tumor cells more sensitive to radiation therapy. Giving motexafin gadolinium together with temozolomide and radition therapy may kill more tumor cells.

Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma

National Cancer Institute (NCI)118 participantsStarted Feb 2006

Mobile, Alabama, United States • Scottsdale, Arizona, United States • Tucson, Arizona, United States +103 more locations

Couples Therapy to Enhance Intimacy Between Patients With Advanced or Recurrent Prostate Cancer and Their Partners

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Find Trials by Condition in Philadelphia

Intraoperative Imaging of Pulmonary Adenocarcinoma

Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine

A Phase II Trial of Perifosine Following Tyrosine Kinase Inhibitor (TKI) - Failure in Patients With Renal Cancer

Combination Therapy Compared With Single-Drug Therapy in Patients With Cardiac Diseases

Early Diagnosis of Pulmonary Nodules

Cardiovascular Improvements With MV ASV Therapy in Heart Failure

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

Treatment of Thrombocytopenia in Patients With Chronic Liver DiseaseUndergoing an Elective Procedure

Using a Motivational Interviewing (MI) Informed Text Messaging Program to Lower Blood Sugar in Diabetic Patients.

Irinotecan-Eluting Beads in Treating Patients With Refractory Metastatic Colon or Rectal Cancer That Has Spread to the Liver

Lactated Ringers With or Without Rectal Indomethacin to Prevent Post-ERCP Pancreatitis

Nutritional Supplementation With Agmatine Sulfate During Small Fiber Neuropathy

Third International Study on Mechanical Ventilation

Deflazacort Expanded Access Program for Children, Adolescents and Adults With Duchenne Muscular Dystrophy

A Phase 1 Study Evaluating CB-5083 in Subjects With Lymphoid Hematological Malignancies

An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

Patient Real-world Clinical, Neurological, Tolerability, and Safety Outcomes for Tecfidera® and Rebif®

Continuation Study of Lapatinib Monotherapy or Lapatinib in Combination With Other Anti-cancer Agents